4 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Inhalation: new trials by email Literature Review of Inhalation trials Research Report on Inhalation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 FB2001, FB2001 placebo - Mild to Moderate COVID-19 | Phase 2 / Phase 3 | Unknown | Frontier Biotechnologies Inc. | 1336 | 2023-01-04 | 2023-01-09 |
| Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure Yiqi Huoxue Huatan granule, Placebo Yiqi Huoxue Huatan granule - Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure | Phase 3 | Unknown | Peking University People's Hospital | 372 | 2019-10-08 | 2020-01-07 |
| Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD Bufei Yishen granule, Placebo Bufei Yishen granule, Tiotropium Bromide Powder for Inhalation - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 348 | 2019-06-01 | 2019-06-06 |
| Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease Acupuncture, Conventional drug, Acupuncture plus conventional drug - Pulmonary Disease, Chronic Obstructive | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 150 | 2017-05-01 | 2017-05-30 |
Pulmonary Disease, Chronic Obstructive (3) · Coronavirus Infections (1)
Henan University of Traditional Chinese Medicine (2) · Frontier Biotechnologies Inc. (1) · Peking University People's Hospital (1)
China (4)
Cheng Yao (1) · Jiansheng Li, Professor (1) · Suyun Li, Doctor (1) · Suyun Li, Professor (1)